Molnupiravir is the first oral antiviral treatment for Covid to report clinical trial results. The first pill designed to treat symptomatic Covid has been approved by the UK medicines regulator. The tablet – molnupiravir – will be given twice a day to vulnerable patients recently diagnosed […]

Click here to view original web page at